Angiocrine Bioscience, Inc. — Form D
Angiocrine Bioscience, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-09-05. The offering totals $3.0M, of which $2.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-09-05
- Form: D
- Accession: 0001569052-25-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $2.1M
- Remaining: $900K
- Investors: 16
- Date of first sale: 2025-08-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-556712
Issuer
- Name: Angiocrine Bioscience, Inc.
- CIK: 0001569052
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 11585 SORRENTO VALLEY RD, STE 109, SAN DIEGO, CA, 92121
- Phone: 858-436-8047
Officers, directors & promoters (21)
| Name | Role | Location |
|---|
| Paul W Finnegan | Director | San Diego, CA |
| David L Parkinson | Director | San Diego, CA |
| Jeffrey L Port | Director | San Diego, CA |
| Paul W Finnegan | Executive Officer | San Diego, CA |
| John R Jaskowiak | Executive Officer | San Diego, CA |
| John T Lomoro | Executive Officer | San Diego, CA |
| Marc Cohen | Director | Chicago, IL |
| PAUL FINNEGAN | Director | CHICAGO, IL |
| PAUL FINNEGAN | Executive Officer | CHICAGO, IL |
| Jeff Jonas | Director | Littleton, CO |
| Jeffrey Port | Director | New York, NY |
| John Jaskowiak | Executive Officer | San Diego, CA |
| John Lomoro | Executive Officer | San Diego, CA |
| David Parkinson | Director | San Diego, CA |
| Claude Geoffrey Davis, Ph.D. | Director | New York, NY |
| Claude Geoffrey Davis, Ph.D. | Executive Officer | New York, NY |
| John Geoffrey Klacking, Ph.D. | Director | New York, NY |
| John Geoffrey Klacking, Ph.D. | Executive Officer | New York, NY |
| Jeffrey L Port, M.D. | Director | New York, NY |
| Brad Geoffrey Daniel | Director | New York, NY |
| Rick Geoffrey Murdock | Director | New York, NY |
Other filings by this issuer (2)
More